Stay updated on Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- Check4 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, and the standard header/footer are shown; this indicates access is blocked to the record.SummaryDifference17%

- Check38 days agoChange DetectedThe page now includes a U.S. NIH grant/contract attribution and the revision is updated to v3.6.6 (replacing v3.6.5), indicating an update to the study record.SummaryDifference0.0%

- Check53 days agoChange DetectedA new recruitment site in Buenos Aires, Argentina (Neurologia Infantil Buenos Aires, C1182ACA) was added, and the previously listed site Instituto de Investigaciones Metabolicas (Idim, C1012AAR) was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, signaling a small update to the page's metadata. The core study details and visible content remain unchanged.SummaryDifference0.0%

- Check67 days agoChange DetectedThe Ukraine locations were updated to Zaporizhzhya, Ukraine (replacing Zaporizhzhia) for two site entries (69035 and 69600).SummaryDifference0.0%

- Check74 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating an internal update to the page or system with no apparent user-facing content changes.SummaryDifference0.0%

Stay in the know with updates to Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.